Dasatinib Added to Chemotherapy for Newly Diagnosed Philadelphia Chromosome Positive Leukemia (ALL)
Clinical Trial
Offered by: ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's
Locations: Delaware Valley
Trial Name
A Phase 2 Multicenter Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
What is the trial about?
To look at the survival rate when a drug called dasatinib is added to standard chemotherapy.
Who can participate?
Age > 1 year and < 18
What is involved?
Length of study is approximately 7 years. Tests and procedures to be done include: Review of medical history; Complete physical exam; Assessment of performance status; Chest X-ray; ECG; ECHO); Collection of blood and urine samples; Spinal tap; DXA; minimal residual disease test; pregnancy test.
Is a Clinical Trial Right for Your Child?
Learn more about clinical trials and get answers to questions you might have.
